相关实验视频

Updated: Sep 13, 2025

Minimally Invasive Treatment for Thoracolumbar Burst Fracture Using Sagittal Alignment Screws and A Trauma Reduction Device

Minimally Invasive Treatment for Thoracolumbar Burst Fracture Using Sagittal Alignment Screws and A Trauma Reduction Device

Published on: November 8, 2024

在脊椎手术中GLP-1受体激动剂是否安全:系统性审查

Iyan Younus¹, Rafael Garcia de Oliveira¹, Takeshi Fujii¹

¹Department of Neurosurgery, Center for Neurosciences and Spine, Virginia Mason Franciscan Health, Seattle, WA.

|July 28, 2025

概括

类似葡萄糖-1受体激动剂 (GLP-1RA) 在脊椎手术的结果中显示出不同的结果. 需要进一步的前性研究来澄清它们对并发症和康复的影响.

科学领域:

内分泌学在内分泌学.
神经外科神经外科
药理学药理学是指药理学的学科.

背景情况:

葡萄糖类-1受体激动剂 (GLP-1RA) 越来越多地用于血糖控制和减肥.
关于GLP-1RA在脊椎外科手术中的安全性和有效性的数据有限.

研究的目的:

系统地审查GLP-1RA对脊柱手术结果的影响.
评估GLP-1RA的一般益处和不良影响.
讨论接受脊椎手术的GLP-1RA患者的术后管理方面的考虑.

主要方法:

使用PubMed和Embase进行系统的文献审查.
关键词包括GLP-1RAs,semaglutide,脊柱手术,脊柱融合和特定的脊柱区域 (宫,胸部,腰部).
纳入标准侧重于评估GLP-1 RA在脊椎外科手术中的利用率的研究.

主要成果:

包括十项回顾性研究,产生异质和矛盾的发现.
医疗并发症,手术后果,再入院和伪关节炎的结果各不相同,一些研究报告了GLP-1RA队列中有利的,模两可的或不利的结果.
四项研究表明,GLP-1 RA使用时伪形的几率较低,而一项研究报告了更高的几率.

结论:

目前在脊椎外科手术中对GLP-1RA进行回顾性研究的证据是混合的和不确定的.
潜在的未测量混因素限制了对现有数据的解释.
前性研究对于建立因果关系和更好地了解GLP-1RA在脊柱外科手术中的术后影响至关重要.

关键词:

这就是GLP-1.融合融合融合融合融合融合融合融合融合类似于葡萄糖的-1 结果就是结果.在安全方面,安全是安全的.塞马格卢提德 (semaglutide) 是一种可怕的药物.脊柱外科手术脊柱外科手术

更多相关视频

Surgical Approach and Complications of Stand-alone Lateral Trans-Psoas Interbody Fusion

Surgical Approach and Complications of Stand-alone Lateral Trans-Psoas Interbody Fusion

Published on: February 14, 2025

Pedicle Screw Placement Using an Augmented Reality Head-Mounted Display in a Porcine Model

Pedicle Screw Placement Using an Augmented Reality Head-Mounted Display in a Porcine Model

Published on: May 24, 2024

相关概念视频

Local Anesthetics: Clinical Application as Spinal Anesthesia

Local Anesthetics: Clinical Application as Spinal Anesthesia

Spinal anesthetics are given during lower abdomen and limb surgeries to block sensory and motor neurons. They are administered in the mid to low lumbar regions, primarily acting on the cauda equina's nerve roots. The blockade level depends on the local anesthetic (LA) concentration. Usually, low LA concentrations are sufficient to block sensory fibers, while only high LA concentrations block motor fibers. Other factors like injection volume and speed, the patient's posture, and the drug...

Glucagon-like Receptor Agonists

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...